ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

Screening

Screening

In this interview we review recent breast cancer screening guidelines from the ACS and USPSTF, and discuss the changing way that early-stage breast and prostate cancers are being treated.

The incidence of early-stage prostate cancer in men 50 years and older continued a decline reported earlier, with lower rates in 2013 compared to 2012. This is a likely result of the October 2011 recommendation from the USPSTF against routine PSA testing in all men.

In this interview we discuss PSA screening for prostate cancer, the compromised results of the PLCO trial, and more.

A recent study found that radiologists differ in their interpretation of whether a woman has dense breasts based on mammography.

Higher than average PSA levels in middle age may be predictive of a higher risk of lethal prostate cancer later in life.

The UK Lung Cancer Screening Trial found that a low-dose CT screening program targeting high-risk individuals can find lung cancer at early stages.

The accuracy of interpreting a breast cancer screening mammogram is not diminished as clinicians get toward the end of a session.

Pages

Subscribe to Screening on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.